PTC Therapeutics reported $-1.2 in EPS Earnings Per Share for its fiscal quarter ending in March of 2024.

Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 -1.20 -1.29 -1.88 Apr/25 2024
FY2023Q4 Dec/2023 -2.06 -0.14 -1.89 Feb/29 2024
FY2023Q3 Sep/2023 -1.76 -1.07 -1.53 Oct/26 2023
FY2023Q2 Jun/2023 -2.66 -1.42 -2.13 Aug/03 2023
FY2023Q1 Mar/2023 -1.88 -1.73 -1.78 Apr/27 2023
FY2022Q4 Dec/2022 -1.89 -1.67 -2.03 Feb/21 2023
FY2022Q3 Sep/2022 -1.53 -1.33 -1.89 Oct/27 2022
FY2022Q2 Jun/2022 -2.13 -1.40 -1.68 Aug/04 2022
FY2022Q1 Mar/2022 -1.78 -1.53 -1.83 May/03 2022
FY2021Q4 Dec/2021 -2.03 -1.52 -1.08 Feb/22 2022
FY2021Q3 Sep/2021 -1.89 -1.47 -1.03 Oct/28 2021
FY2021Q2 Jun/2021 -1.68 -1.88 -2.62 Jul/29 2021

Eps Change Date
Acadia Pharmaceuticals USD 0.28 0.68 Dec/2023
Alnylam Pharmaceuticals USD -1.1 2.25 Dec/2023
Amgen USD 4.71 0.25 Dec/2023
Biogen USD 3.67 0.37 Mar/2024
BioMarin Pharmaceutical USD 0.71 0.53 Mar/2024
Cytokinetics USD -1.38 0.03 Dec/2023
Daiichi Sankyo JPY 7.3 27.39 Mar/2024
Gilead Sciences USD 1.72 0.57 Dec/2023
Incyte USD 1.06 0.04 Dec/2023
Ionis Pharmaceuticals USD -0.06 0.97 Dec/2023
Ironwood Pharmaceuticals USD -0.01 0.1 Dec/2023
Novartis USD 1.8 0.27 Mar/2024
Pfizer USD 0.1 0.27 Dec/2023
PTC Therapeutics USD -1.2 0.96 Mar/2024
Roche Holding CHF 8.47 1.63 Dec/2023
Sarepta Therapeutics USD 0.47 0.93 Dec/2023
TG Therapeutics USD -0.1 0.83 Dec/2023
Ultragenyx Pharmaceutical USD -1.52 0.71 Dec/2023
Vertex Pharmaceuticals USD 4.2 0.12 Dec/2023
Xencor USD -0.31 0.09 Dec/2023